InvestSMART

Paradigm Biopharmaceuticals Limited (ASX: PAR) - Announcements

Current share price for PAR : $0.170 0.01 (5.56%)+

ASX company news and announcements for Paradigm Biopharmaceuticals Limited (PAR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Paradigm Biopharmaceuticals Limited (PAR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Paradigm Biopharmaceuticals Limited (PAR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Paradigm Biopharmaceuticals Limited (PAR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$102 Appendix 4C - quarterly 31 Jul 2019 11:40AM $1.470 $0.170 fallen by 88.44%
$102 Response to ASX Appendix 3Y Query 5 Jul 2019 9:18AM $1.425 $0.170 fallen by 88.07%
$102 Change of Director's Interest Notice 3 Jul 2019 9:36AM $1.385 $0.170 fallen by 87.73%
$102 Change in substantial holding 2 Jul 2019 9:51AM $1.370 $0.170 fallen by 87.59%
$102 Change of Director's Interest Notice 2 Jul 2019 9:46AM $1.370 $0.170 fallen by 87.59%
$102 Paradigm EOFY Update 28 Jun 2019 1:10PM $1.380 $0.170 fallen by 87.68%
$102 PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL 4 Jun 2019 8:31AM $1.450 $0.170 fallen by 88.28%
$102 PAR reports consistent pain reduction in knee OA of patients 28 May 2019 8:24AM $1.480 $0.170 fallen by 88.51%
$102 PAR CORRECTS AFR ARTICLE 21 May 2019 11:40AM $1.495 $0.170 fallen by 88.63%
$102 Updated Appendix 3B 13 May 2019 9:45AM $1.450 $0.170 fallen by 88.28%
$102 Appendix 3B 13 May 2019 8:36AM $1.450 $0.170 fallen by 88.28%
$102 Successful Completion of Retail Entitlement Offer 9 May 2019 8:23AM $1.510 $0.170 fallen by 88.74%
$102 Paradigm Corporate Update - May 2019 8 May 2019 8:23AM $1.530 $0.170 fallen by 88.89%
$102 Quarterly Report and Appendix 4C - quarterly 30 Apr 2019 11:41AM $1.550 $0.170 fallen by 89.03%
$102 Appendix 3B 26 Apr 2019 9:06AM $1.585 $0.170 fallen by 89.27%
$102 Cleansing Notice under section708A 26 Apr 2019 9:05AM $1.585 $0.170 fallen by 89.27%
$102 Completion of Institutional Entitlement Offer 24 Apr 2019 9:39AM $1.645 $0.170 fallen by 89.67%
$102 Cleansing statement under Section 708AA 24 Apr 2019 8:26AM $1.645 $0.170 fallen by 89.67%
$102 Change of Director's Interest Notice 23 Apr 2019 4:43PM $1.645 $0.170 fallen by 89.67%
$102 PAR Accelerated Non-Renounceable Rights Issue Offer Booklet 17 Apr 2019 9:00AM $1.900 $0.170 fallen by 91.05%
$102 Paradigm Confirms Capital Raise Commitments 17 Apr 2019 8:58AM $1.900 $0.170 fallen by 91.05%
$102 PARADIGM UPDATED CORPORATE PRESENTATION 15 Apr 2019 9:31AM $1.900 $0.170 fallen by 91.05%
$102 Appendix 3B 15 Apr 2019 9:29AM $1.900 $0.170 fallen by 91.05%
$102 PARADIGM LAUNCHES A$77.9M CAPITAL RAISE 15 Apr 2019 9:21AM $1.900 $0.170 fallen by 91.05%
$102 Cleansing statement under Section 708AA 15 Apr 2019 9:17AM $1.900 $0.170 fallen by 91.05%

501 - 525 of 721 results

Page 21 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.